Premium HealthCare UK Telmisartan 20mg is an angiotensin II receptor blocker with unique partial PPAR-gamma agonist activity studied for cardiovascular and metabolic research.
Key Details
– 150 tablets x 20mg
– Oral administration
Research Benefits
– AT1 receptor blockade for blood pressure management research
– Partial PPAR-gamma agonism provides metabolic benefits beyond blood pressure
– Studied for cardiovascular risk reduction and renal protection
– Longest half-life among ARBs at approximately 24 hours
– Metabolic syndrome and insulin sensitivity research applications
Suggested Research Protocol
– Dose: 20 to 80mg once daily oral
Quality Assurance: Pharmaceutical grade, batch verified.
Reviews
There are no reviews yet.